Minrun Duan
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera.
Journal: NPJ vaccines
Published: July 10, 2024
Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19.
Journal: Journal of medical virology
Published: April 13, 2023
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine.
Journal: Cell discovery
Published: March 14, 2023
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
Journal: The New England journal of medicine
Published: March 01, 2023
A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5.
Journal: Emerging microbes & infections
Published: February 21, 2023
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
Journal: Lancet (London, England)
Published: February 09, 2023
Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™.
Journal: Vaccine
Published: October 04, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026